Article citationsMore>>
B. I. Rini, B. Escudier, P. Tomczak, A. Kaprin, T. E. Hutson, C. Szczylik, J. C. Tarazi, B. Rosbrook, S. Kim and R. J. Motzer, “Axitinib versus Sorafenib as Second-Line Therapy For Metastatic Renal Cell Carcinoma (mRCC): Results of Phase III AXIS Trial.,” Journal of Clinical Oncology, Vol. 29, Suppl. 15, 2011, Abstract No. 4503.
has been cited by the following article:
Related Articles:
-
Kazuhiro Murakami, Kazuhiko Yamamoto, Kumiko Aoki, Ikuyo Fukumoto, Tsutomu Sugiura, Tadaaki Kirita
-
Jai Dev Chandel, Nand Lal Singh
-
Jinjing Chen, Haizhen Yi, Hong Cen, Wei Yan
-
Axel Costilla-Montero, Benjamín Guadarrama-Benítez, Marco A. Aragón-Castro, Omar Morales-Ordaz, Rubén Gutiérrez-Rosales, Claudia Carrillo-Ponce, Marcela Janka-Zires, Luis Gabriel Vázquez-Lavista
-
Haruchika Yamamoto, Yuji Hirami, Tomohiro Toji, Yoko Shinno, Tetsuya Ota, Minoru Naito, Akio Andou